Discovery of an inhibitor of DNA-driven inflammation that preferentially targets the AIM2 inflammasome (2023)
Attributed to:
New insights into NLRP3 within inflammatory disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.isci.2023.106758
PubMed Identifier: 37216118
Publication URI: http://europepmc.org/abstract/MED/37216118
Type: Journal Article/Review
Parent Publication: iScience
Issue: 5
ISSN: 2589-0042